Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksARDN.L Regulatory News (ARDN)

  • There is currently no data for ARDN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Statement

20 Mar 2019 07:00

RNS Number : 3317T
Arden Partners plc
20 March 2019
 

Arden Partners plc

("Arden" or the "Company")

 

Annual General Meeting Statement 2019

 

 Arden Partners plc (AIM: ARDN), the institutional stockbroking company, will hold its Annual General Meeting ("AGM") at 12.30 pm today at 125 Old Broad Street, London EC2N 1AR.

 

The following statement will be made at the AGM:

 

"As predicted in the 2018 Annual Report, market conditions have remained challenging and we expect them to continue to be so in the short term.

 

Nevertheless, in the year to date we have completed a number of fundraisings and advisory transactions on behalf of our corporate clients.

 

Furthermore, we have continued to grow our corporate client base which remains key to our strategy.

 

The Company's balance sheet remains strong and despite the market challenges we have a good pipeline of corporate business."

 

For further enquiries:

 

Arden Partners plc

020 7614 5900

Donald Brown - Chief Executive Officer

James Reed-Daunter - Executive Director

Steve Douglas - Group Finance Director

 

GCA Altium Limited

020 7484 4040

Sam Fuller / Tim Richardson

 

 

Notes for editors

 

Arden is a dedicated corporate adviser and multi-service stockbroker to small and mid-cap companies in the UK and their investors.

 

The absolute core of our business is the effective management of the needs of our significant and growing base of corporate clients, and the effective support of their relationships with existing and potential shareholders. 

 

These relationships are enhanced by the quality of our corporate finance advice and industry research, and the strong market presence of our sales and trading teams.

 

Our corporate finance capabilities encompass M&A, corporate finance advisory, broking and Sponsor and NOMAD services. We represent our clients in private transactions and AIM and Main Market share issues.

 

Our research is designed to be sector focused, concentrating on top down thematic trends which highlight companies giving investors an exposure to the real growth areas of the small-cap and AIM markets.

 

It is the job of the sales team to keep institutions abreast of these themes and stock ideas. When there is a requirement for our corporate clients to raise money to fulfil their growth ambitions, the sales team is in a strong position to effect this, with its entrenched relationships with the UK institutional and non-institutional markets.

 

Our market making and trading teams provide liquidity in the shares of our corporate clients. We also trade the shares of non-client corporates on behalf of institutions.

 

The recently added Arden Wealth Management team offers a bespoke discretionary service to our clients, with the ability to trade/invest in equities, bonds and a range of global investment funds.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGMUKVURKVAOAAR
Date   Source Headline
22nd Jan 201011:17 amRNSEPT Disclosure
20th Jan 201010:46 amRNSEPT Disclosure
11th Jan 201011:32 amRNSEPT Disclosure
7th Jan 201011:53 amRNSEPT Disclosure
5th Jan 201011:01 amRNSEPT Disclosure
4th Jan 201011:24 amRNSEPT Disclosure
31st Dec 200910:04 amRNSEPT Disclosure
23rd Dec 200911:46 amRNSEPT Disclosure
22nd Dec 200911:09 amRNSEPT Disclosure
21st Dec 200911:46 amRNSEPT Disclosure
18th Dec 20093:59 pmRNSEPT Disclosure
11th Dec 200911:30 amRNSEPT Disclosure
26th Nov 200911:59 amRNSEPT Disclosure
25th Nov 200911:40 amRNSEPT Disclosure
23rd Nov 200910:07 amRNSBlocklisting Return
16th Nov 200910:29 amRNSEPT Disclosure
2nd Nov 200911:38 amRNSTotal Voting Rights
14th Sep 20094:08 pmRNSEBT purchase
4th Sep 200911:20 amRNSEPT Disclosure
1st Sep 20091:59 pmRNSTotal Voting Rights
1st Sep 200910:31 amRNSEPT Disclosure
25th Aug 200910:01 amRNSEPT Disclosure
20th Aug 200911:23 amRNSEPT Disclosure
19th Aug 200911:29 amRNSEPT Disclosure
18th Aug 200910:24 amRNSEPT Disclosure
14th Aug 200910:21 amRNSEPT Disclosure
13th Aug 200911:28 amRNSEPT Disclosure
11th Aug 200911:41 amRNSEPT Disclosure - Amendment
11th Aug 200911:24 amRNSEPT Disclosure
10th Aug 20099:47 amRNSEPT Disclosure
6th Aug 20099:47 amRNSEPT Disclosure
5th Aug 200910:48 amRNSEPT Disclosure
31st Jul 20099:29 amRNSEPT Disclosure
30th Jul 200910:45 amRNSEPT Disclosure
24th Jul 20091:16 pmRNSDirector's dealing
24th Jul 200910:08 amRNSEPT Disclosure
23rd Jul 20099:19 amRNSEPT Disclosure
17th Jul 20091:44 pmRNSEBT Purchase
14th Jul 20097:00 amRNSInterim results
10th Jul 200910:08 amRNSEPT Disclosure
9th Jul 20099:56 amRNSEPT Disclosure
3rd Jul 20097:00 amRNSNotice of Results
1st Jul 20099:31 amRNSEPT Disclosure
25th Jun 20099:52 amRNSEPT Disclosure
24th Jun 200911:01 amRNSEPT Disclosure
23rd Jun 200910:17 amRNSEPT Disclosure
15th Jun 200912:13 pmRNSAndrew Heath Appointed Head of Equities
12th Jun 200910:43 amRNSEPT Disclosure
11th Jun 200910:15 amRNSEPT Disclosure
10th Jun 200910:26 amRNSEPT Disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.